Pharmacovigilance Inspections and Audit Readiness Masterclass

“Helping you prepare on your journey to compliance and inspection readiness"
Date
2015-09-24 - 2015-09-25
Organizer
Exhibitors
2
Floor Size
200
Attendees
30
Event contact title
Mrs
Event contact first name
Andrea
Event contact last name
Weber
Email
andrea.weber@flemingeurope.com
Event contact telephone number
+421 257 272 155
Notes
For further information about the event, cost and registration please contact Andrea Weber via andrea.weber@flemingeurope.com or call +421 257 272 155.
Description
This course will give a clear understanding of what to expect of inspections as well as how to ensure full compliance with regulatory requirements. Directive 2010/84/EU legislation has navigated post-marketing drug safety towards higher standards, meaning lack of compliance will not only impact a company‘s public image but result in hefty fines. Therefore, closer communication with regulators is crucial not only for minimum compliance but for further enhancement of patient safety standards. key topics: *GVP Modules 3 and 4 *Pharmacovigilance Master File *Quality Management System *Regulatory Expectations *Audit findings *Quality Assurance *QPPV's Role within the Inspection *Interactive Session: Practical Aspects in Pv Inspections and Audits Our Prominent Trainer Shelley Gandhi Pharmacovigilance Director NDA Group, United Kingdom

Partner Voices

Until recently, the opportunity to have a celebrity attend an event, attach themselves to a name-brand or endorse a certain product or idea was untouchable. The thought of paying a person to promote a product was seen as something only Fortune 500 companies could afford. Social media has changed all that with brands and businesses utilizing celebrity influencers to connect directly with their demographics and increase sales and profits.